These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 89540)

  • 1. Rebound effect after somatostatin treatment in Verner-Morrison syndrome.
    Bonfils S; René E; Pignal F; Rambaud JC
    Lancet; 1979 Sep; 2(8140):476. PubMed ID: 89540
    [No Abstract]   [Full Text] [Related]  

  • 2. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
    Fahrenkrug J; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersecretion of calcitonin in patients with the Verner-Morrison syndrome.
    Oberg K; Lööf L; Boström H; Grimelius L; Fahrenkrug J; Lundqvist G
    Scand J Gastroenterol; 1981; 16(1):135-44. PubMed ID: 6262904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
    Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
    Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The vaso-active intestinal polypeptide in Verner-Morrison syndrome].
    Seif FJ; Sadowski P; Heni F; Fischer R; Bloom SR; Polak JM
    Dtsch Med Wochenschr; 1975 Feb; 100(9):399-405. PubMed ID: 163727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects fo streptozotocin in the WDHA syndrome not amenable to radical surgery.
    Biliotti G; Masi C; Macchini M; Bani Sacchi T; Bartolini G; Stefani P; Tonelli F
    J Endocrinol Invest; 1980; 3(3):297-300. PubMed ID: 6253557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoglucagonoma responsive to somatostatin.
    Lubetzki J; Guillausseau PJ; Binet O; Hautefeuille P; Galian A; Mundler O; Aron-Brunetiere R; Timsit J; Warnet A
    Lancet; 1981 Aug; 2(8241):316-7. PubMed ID: 6114367
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
    Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
    N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
    [No Abstract]   [Full Text] [Related]  

  • 9. [Case of Verner-Morrison syndrome].
    Merdzhanov M; Damianov D; Mendizova A; Damianov B; Bozhanov V
    Khirurgiia (Sofiia); 1979; 32(4):352-6. PubMed ID: 229304
    [No Abstract]   [Full Text] [Related]  

  • 10. The glucagonoma syndrome.
    Bloom SR; Sonksen PH
    J R Soc Med; 1990 Jan; 83(1):60. PubMed ID: 1968103
    [No Abstract]   [Full Text] [Related]  

  • 11. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
    Santangelo WC; Dueno MI; Krejs GJ
    Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatostatin and analogues in the treatment of VIPoma.
    O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS
    Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913
    [No Abstract]   [Full Text] [Related]  

  • 13. Streptozotocin treatment of a juvenile onset type diabetic patient with Verner-Morrison syndrome and multi hormonal probable malignant islet cell carcinoma with liver metastases.
    Granuci P; Mahler RJ
    Horm Metab Res; 1982 Jun; 14(6):327-8. PubMed ID: 6288539
    [No Abstract]   [Full Text] [Related]  

  • 14. The glucagonoma syndrome.
    Sonksen PH; Bloom SR
    J R Soc Med; 1990 Feb; 83(2):127. PubMed ID: 1969482
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of insulinoma with the somatostatin analog SMS 201-995].
    Gilsanz Peral A; Gómez Balaguer M; Costa Talens P
    Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658
    [No Abstract]   [Full Text] [Related]  

  • 16. Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
    Clements D; Elias E
    Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunhistologic, cytochemical, and electron-microscopic investigations in Verner-Morrison syndrome (WDHA-syndrome, pancreatic cholera) (author's transl)].
    Burkhardt A; Mitschke H
    Virchows Arch A Pathol Anat Histol; 1974; 364(2):145-63. PubMed ID: 4371730
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
    Juby LD; Burke DA; Axon AT
    Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Verner-Morrison syndrome with non-tumoral form. A case].
    Rambaud JC; Mignon F; Hautefeuille P; Potet F; Bognel C; Modigliani R; Bourel M; Bernier JJ
    Rev Med Chir Mal Foie; 1970; 45(5):261-9. PubMed ID: 4320466
    [No Abstract]   [Full Text] [Related]  

  • 20. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?
    Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR
    Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.